Tag: 4

Toronto, June 10, 2026 (GLOBE NEWSWIRE) -- On June 9, 2026, Visionary Holdings Inc. (the “Company”, Nasdaq ticker: GV) announced that on June 4, 2026, it received a Staff Determination Letter from the Nasdaq Listing Qualifications Department, in which Nasdaq regulatory staff formally determined to delist the Company’s securities.

LOS ANGELES, June 10, 2026 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.

TEL AVIV, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced the closing of Teva’s acquisition of Emalex Biosciences, strengthening its late-stage pipeline with ecopipam and further advancing its Pivot to Growth strategy. Phase 3 data for ecopipam were recently published in JAMA Neurology, and a U.S. NDA submission is anticipated in the second half of 2026.